NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

NCT00356954 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: N-acetylcystein
DRUG: ascorbic acid

Sponsor

Seoul National University Hospital